Shiv Kumar Sarin, MD, DM
Institute of Liver and Biliary Sciences, New Delhi, India

Title: Non-communicable Diseases and MASLD: Policy Gaps and Action Points

Ashwani K. Singal, MD
University of Louisville School of Medicine, KY, USA

Title: Emerging Liver Targeted Pharmacologic Treatments for MASH

Saumya Jayakumar, MD
University of Alberta, Edmonton, Canada

Title: MASLD and Pregnancy – Considerations and Management

Prosenjit Mondal, PhD
IISER Berhampur, India

Title: Exploring Liver-to-Pancreatic Islet Communication to Uncover Mechanisms that Propel β-cell Dysfunction in MAFLD

Takhar Kasumov, PhD
Northeast Ohio Medical University, OH, USA

Title: Impact of High Fat Diet-Induced MASLD on Tau Pathology in hTau Mouse Model

Winston Dunn, MD
University of Kansas Medical Center, KS, USA

Title: Sex-Specific Risk Thresholds of Binge Drinking Frequency for Advanced Fibrosis in the United States

William Alazawi, MB PhD
Queen Mary University of London, United Kingdom

Title: Advances in the Pathogenesis of MASH and Fibrosis

Partha Chakrabarti, MD, PhD
CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, India

Title: Proteotoxicity in MASLD

Rahima A. Bhanji, MD
University of Alberta, Edmonton, Canada

Title: Sarcopenia in MASLD

Rohit A. Sinha, PhD
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Title: Hormonal Therapy for MASH

Prasanna Kumar Santhekadur, PhD
JSS Medical College, Mysore, India

Title: Novel Insights on Beneficial Role Dietary Short Chain Fatty Acids (SCFAs) on Metabolic Dysfunction-Associated Steatotic Liver Disease and HCC